OASIS
Research type
Research Study
Full title
ObservAtional study to investigate Surgical site INfection in ulcerated Skin cancers (OASIS)
IRAS ID
243011
Contact name
Rachel Abbott
Contact email
Sponsor organisation
Cardiff and Vale University Health Board
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 9 months, 1 days
Research summary
We aim to recruit 311 participants to this study from three UK Dermatology departments. We will invite people with suspected skin cancers whose lesions have a broken surface (also known as ulcerated) who will undergo surgery.
This study is being carried out because it is possible that patients with skin cancers with ulceration might be at greater risk of developing a wound infection after surgery. The aim of this study is to determine how many people with ulcerated skin cancers develop an infection of the wound after it has been surgically removed.
People with ulcerated skin cancers who will have surgery will be invited to participate in the study. If they agree, a member of the research team will explain the study and consent them to participate in the study. At the time of surgery, information will be collected about the participant, skin tumour and procedure. The participant will be given standardised advice regarding wound care and further care will be as per each centre’s ‘normal clinical care’. If participants are diagnosed with a wound infection then they will asked to take a ‘wound selfie’ and share the photo with the research team. The research team will contact the participant via a questionnaire which will be sent via post or e-mail four weeks after the procedure to determine whether they had any concerns about post-operative infection and whether any action was taken.Additionally, all participants at the University Hospital of Wales will have a surface swab taken from their ulcerated skin cancer and these will be analysed in the Public Health Wales laboratory at the University Hospital of Wales, Cardiff. The aim of this aspect of the study is to identify the most common bacteria in ulcerated tumours.REC name
South Central - Hampshire B Research Ethics Committee
REC reference
19/SC/0047
Date of REC Opinion
6 Feb 2019
REC opinion
Further Information Favourable Opinion